Skip Navigation Links
Home
About Us
Markets
Products
Sustainability
Innovation
Links
News


 
Sodium Carbonate Pharmaceutical Grade 

According to the current European legislation (2001/83/EC) APIs have to be manufactured under GMP conditions, as defined in the EUDRALEX Vol. 4 part II. Sodium Carbonate IPH fulfills these requirements and can therefore be used as active pharmaceutical ingredient in medicinal products.

 
TabPanel1
AJAX PANE
AJAX HAS BEEN KNOW TO ENHANCE USER INTERFACE
AJAX HAS BEEN KNOW TO ENHANCE USER INTERFACE
AJAX HAS BEEN KNOW TO ENHANCE USER INTERFACE
AJAX HAS BEEN KNOW TO ENHANCE USER INTERFACE
Expand All Collapse All
Product DescriptionApplicationsPackaging

Sodium Carbonate anhydrous is a white, crystalline, hygroscopic powder.

Sodium Carbonate is an inorganic salt with a melting point of 851 °C. It decomposes, when being heated at more than 400 °C under release of CO2 gas.
Sodium carbonate is a strong alkaline substance with a pH of 11.6 for a 0.1 M aqueous solution. When being neutralized with acids CO2 gas is released:

                          Na2CO3 + 2 HCl -->  2 NaCl + H2O + CO2

               Na2CO3 + 2 CH3COOH --> 2 CH3COONa + H2O + CO2

Due to its hygroscopicity Sodium Carbonate Anhydrous attracts water under formation of monohydrate thus demonstrating its desiccation property. 

                             Na2CO3 + H2O   --> Na2CO3 * H2

 
For more information, please contact: 
 
Michael STEINER
michael.steiner@solvay.com
Office:+49 2843 73 2660
 
 
 
 
 
 

In February 2011 the European Directorate for the Quality of Medicines (EDQM) granted us a CEP (= Certificate of Suitability of the monograph of the European Pharmacopoeia).

This step clearly shows our quality commitment towards the Healthcare industry.

The CEP certificate simplifies the marketing authorization process of our customers and is even recognized by a number of non EU countries and institutions

 
 
 
Current Site > Solvay Chemicals
 
© Copyright 2011 Skip Navigation Links
Last update 19/4/2011